Texas Biotechnology Corporation
1 clinical trials · Sponsor
◉ Watch Texas Biotechnology Corporation
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis (NCT00035178) | Texas Biotechnology Corporation | 2002-05-01 |
Track Texas Biotechnology Corporation automatically
Every clearance here is in the API, with alerts when new ones post.